Tiziana Life Sciences (TLSA) Competitors $2.29 +0.12 (+5.53%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$2.26 -0.03 (-1.31%) As of 10/8/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLSA vs. TNGX, PHAR, IMTX, UPB, RLAY, TSHA, CRMD, URGN, RZLT, and ABUSShould you be buying Tiziana Life Sciences stock or one of its competitors? The main competitors of Tiziana Life Sciences include Tango Therapeutics (TNGX), Pharming Group (PHAR), Immatics (IMTX), Upstream Bio (UPB), Relay Therapeutics (RLAY), Taysha Gene Therapies (TSHA), CorMedix (CRMD), Urogen Pharma (URGN), Rezolute (RZLT), and Arbutus Biopharma (ABUS). These companies are all part of the "pharmaceutical products" industry. Tiziana Life Sciences vs. Its Competitors Tango Therapeutics Pharming Group Immatics Upstream Bio Relay Therapeutics Taysha Gene Therapies CorMedix Urogen Pharma Rezolute Arbutus Biopharma Tiziana Life Sciences (NASDAQ:TLSA) and Tango Therapeutics (NASDAQ:TNGX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations, valuation and media sentiment. Do analysts recommend TLSA or TNGX? Tango Therapeutics has a consensus target price of $10.50, indicating a potential upside of 51.95%. Given Tango Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Tango Therapeutics is more favorable than Tiziana Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tiziana Life Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Tango Therapeutics 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.67 Do insiders and institutionals believe in TLSA or TNGX? 79.0% of Tango Therapeutics shares are owned by institutional investors. 39.8% of Tiziana Life Sciences shares are owned by company insiders. Comparatively, 7.5% of Tango Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is TLSA or TNGX more profitable? Tiziana Life Sciences has a net margin of 0.00% compared to Tango Therapeutics' net margin of -599.11%. Tiziana Life Sciences' return on equity of 0.00% beat Tango Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Tiziana Life SciencesN/A N/A N/A Tango Therapeutics -599.11%-79.72%-49.30% Which has more risk & volatility, TLSA or TNGX? Tiziana Life Sciences has a beta of -0.37, indicating that its stock price is 137% less volatile than the S&P 500. Comparatively, Tango Therapeutics has a beta of 1.67, indicating that its stock price is 67% more volatile than the S&P 500. Which has stronger earnings and valuation, TLSA or TNGX? Tiziana Life Sciences has higher earnings, but lower revenue than Tango Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTiziana Life SciencesN/AN/A-$11.86MN/AN/ATango Therapeutics$24.30M31.64-$130.30M-$1.33-5.20 Does the media favor TLSA or TNGX? In the previous week, Tango Therapeutics had 2 more articles in the media than Tiziana Life Sciences. MarketBeat recorded 3 mentions for Tango Therapeutics and 1 mentions for Tiziana Life Sciences. Tango Therapeutics' average media sentiment score of 0.51 beat Tiziana Life Sciences' score of 0.00 indicating that Tango Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Tiziana Life Sciences Neutral Tango Therapeutics Positive SummaryTango Therapeutics beats Tiziana Life Sciences on 8 of the 13 factors compared between the two stocks. Get Tiziana Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TLSA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLSA vs. The Competition Export to ExcelMetricTiziana Life SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$253.56M$3.35B$6.10B$10.55BDividend YieldN/A2.28%5.69%4.75%P/E RatioN/A21.5785.4727.60Price / SalesN/A426.57601.78232.87Price / CashN/A47.1237.9261.55Price / Book57.2510.1413.136.76Net Income-$11.86M-$52.31M$3.30B$275.88M7 Day Performance14.50%5.14%4.29%2.81%1 Month Performance23.78%14.68%9.45%9.24%1 Year Performance141.08%30.98%86.64%35.42% Tiziana Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLSATiziana Life Sciences0.2376 of 5 stars$2.29+5.5%N/A+147.0%$253.56MN/A0.008Upcoming EarningsAnalyst ForecastGap UpTNGXTango Therapeutics1.9517 of 5 stars$8.44-1.1%$10.50+24.4%+0.3%$949.05M$24.30M-6.3590Analyst ForecastPHARPharming Group2.3135 of 5 stars$14.29+3.6%$30.00+109.9%+69.5%$944.82M$339.84M-109.92280Positive NewsAnalyst ForecastShort Interest ↑Gap UpIMTXImmatics2.427 of 5 stars$7.91+2.7%$15.00+89.6%-5.5%$935.94M$168.65M-12.17260Analyst ForecastUPBUpstream Bio1.8915 of 5 stars$17.34+0.5%$56.50+225.8%N/A$930.47M$2.72M0.0038Analyst ForecastRLAYRelay Therapeutics2.8312 of 5 stars$5.19+0.4%$16.50+217.9%-2.2%$891.37M$10.01M-2.66330Positive NewsTSHATaysha Gene Therapies2.5152 of 5 stars$3.16-2.8%$8.29+162.2%+151.7%$886.58M$8.33M-9.29180Analyst ForecastGap UpCRMDCorMedix2.9122 of 5 stars$11.85+4.9%$18.00+51.9%+16.5%$882.07M$121.48M15.8030Analyst DowngradeURGNUrogen Pharma3.9218 of 5 stars$19.14+4.4%$32.00+67.2%+32.2%$848.48M$90.40M-5.77200Analyst ForecastRZLTRezolute2.6632 of 5 stars$9.29-0.5%$14.50+56.1%+82.4%$848.18MN/A-9.5840Analyst ForecastABUSArbutus Biopharma1.5978 of 5 stars$4.46+1.1%$5.00+12.1%+10.9%$845.39M$6.17M-15.3890Positive NewsAnalyst Forecast Related Companies and Tools Related Companies TNGX Competitors PHAR Competitors IMTX Competitors UPB Competitors RLAY Competitors TSHA Competitors CRMD Competitors URGN Competitors RZLT Competitors ABUS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLSA) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tiziana Life Sciences Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Tiziana Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
